MetaVia new preclinical data supporting the anti-fibrotic potential of vanoglipel (DA-1241) in MASH.
MetaVia announces peer-reviewed Biomolecules & Therapeutics publication of new preclinical data supporting the anti-fibrotic potential of vanoglipel (DA-1241) in MASH.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.